From these 318 patients, sixteen percent of patients had a CHRNA5 expression z-score >1, which we then used as our cutoff in determining which tobacco associated HNSCC patients are considered “CHRNA5 High” (Figure 1E). This evidence concerns the gene CHRNA5 and head and neck squamous cell carcinoma.